# Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease

> **NCT00090558** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 30 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** nitroglycerin

## Key facts

- **NCT ID:** NCT00090558
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090558, "Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00090558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*